Definium Therapeutics, Inc. (DFTX)
37.65
-2.67
(-6.62%)
USD |
NASDAQ |
Sep 23, 16:00
37.46
-0.19
(-0.50%)
Pre-Market: 09:08
Definium Therapeutics Cash from Operations (TTM) : -166.74M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -166.74M |
| March 31, 2026 | -145.05M |
| December 31, 2025 | -131.84M |
| September 30, 2025 | -113.82M |
| June 30, 2025 | -101.18M |
| March 31, 2025 | -90.27M |
| December 31, 2024 | -77.45M |
| September 30, 2024 | -73.36M |
| June 30, 2024 | -72.84M |
| March 31, 2024 | -67.05M |
| December 31, 2023 | -63.78M |
| September 30, 2023 | -55.44M |
| June 30, 2023 | -47.47M |
| March 31, 2023 | -48.54M |
| December 31, 2022 | -48.08M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | -46.03M |
| June 30, 2021 | -35.93M |
| March 31, 2021 | -29.41M |
| December 31, 2020 | -24.89M |
| September 30, 2020 | -16.65M |
| June 30, 2020 | -10.74M |
| March 31, 2020 | -5.274M |
| August 31, 2019 | -0.2087M |
| May 31, 2019 | -0.3933M |
| February 28, 2019 | -0.2612M |
| November 30, 2018 | -0.5824M |
| August 31, 2018 | -0.7052M |
| May 31, 2018 | -0.7012M |
| February 28, 2018 | -0.6378M |
| November 30, 2017 | -0.685M |
| August 31, 2017 | -0.683M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Enliven Therapeutics, Inc. | -66.94M |
| Cocrystal Pharma, Inc. | -8.263M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -207.00M |